This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Why Senomyx (SNMX) Is Lower on Thursday

NEW YORK ( TheStreet) -- Senomyx (SNMX - Get Report) is tumbling on Thursday after posting below-consensus financials in its fourth quarter.

By late afternoon, shares had taken off 5.4% to $10.56.

Trading volume of 1.2 million was nearly double its three-month daily average.

San Deiego-based Senomyx recorded a net loss of 8 cents a share, 2 cents wider than analysts surveyed by Thomson Reuters had anticipated.

Revenue of $7.41 million was short expectations for $7.81 million, and 9.6% lower than a year earlier.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

On Tuesday, shares soared after the company's Sweetmyx ingredient, a flavoring which maintains sweetness in reduced-sugar foods and beverages, was determined to be Generally Recognized as Safe (GRAS) by U.S. regulatory Food and Drug Administration (FDA). PepsiCo (PEP - Get Report) has exclusive rights to use the flavor worldwide in all non-alcohol beverages.

"Senomyx is starting 2014 well-positioned for commercial growth and continued achievements with our R&D and regulatory efforts," said CEO John Poyhonen in a statement.

For fiscal 2014, management expects revenue between $32 million and $35 million with a net loss of 23 cents to 28 cents a share.

Analysts forecast revenue of $35.45 million and a net loss of 15 cents a share.

Must Read: Warren Buffett's 10 Favorite Stocks

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
PEP $96.26 -0.97%
SNMX $5.45 1.30%
AAPL $132.54 0.88%
FB $80.58 0.12%
GOOG $540.32 -0.40%

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs